Steven Treon
MD, PhD
Director, Bing Center for Waldenström's Macroglobulinemia
👥Biography 个人简介
Steven Treon is the world's preeminent authority on Waldenstrom's macroglobulinemia (WM), having discovered the MYD88 L265P somatic mutation as a near-universal driver in WM. He pioneered ibrutinib therapy in WM and identified CXCR4 mutations as a key modifier of ibrutinib response. His discoveries fundamentally transformed WM diagnosis and treatment and catalyzed an era of targeted therapy for this rare lymphoplasmacytic lymphoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Steven Treon 的研究动态
Follow Steven Treon's research updates
留下邮箱，当我们发布与 Steven Treon（Dana-Farber Cancer Institute / Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment